27.03.2024 07:00 | HVO | Notice of Results | RNS |
22.03.2024 15:03 | HVO | Holding(s) in Company | RNS |
18.03.2024 11:23 | HVO | Investment firm European Green Transition plans listing on AIM | Alliance |
14.03.2024 07:00 | HVO | Holding(s) in Company | RNS |
15.02.2024 07:00 | HVO | Long Term Incentive Plan / PDMR Notification | RNS |
14.02.2024 19:55 | HVO | IN BRIEF: hVIVO Chair and non-exec director sell 30.0 million shares | Alliance |
14.02.2024 13:14 | HVO | Result of Secondary Placing | RNS |
14.02.2024 10:46 | HVO | IN BRIEF: hVIVO directors to sell total of 14 million shares | Alliance |
14.02.2024 07:00 | HVO | Proposed Secondary Placing of Ordinary Shares | RNS |
30.01.2024 11:39 | HVO | hVIVO shares up after "record year" across all metrics | Alliance |
30.01.2024 07:00 | HVO | Trading update | RNS |
08.01.2024 07:00 | HVO | Broker change | RNS |
02.01.2024 10:16 | HVO | hVIVO inks GBP6.3 million deal to test common cold treatment | Alliance |
02.01.2024 07:00 | HVO | £6.3m HRV contract signed with biotech client | RNS |
13.12.2023 11:44 | HVO | hVIVO signs deal to test RSV antiviral drug candidate with study model | Alliance |
13.12.2023 07:00 | HVO | £16.8m RSV contract & Trading ahead of guidance | RNS |
05.10.2023 11:45 | HVO | hVIVO celebrates positive results for Pneumagen's Neumifil in trial | Alliance |
05.10.2023 07:00 | HVO | Positive results from flu human challenge study | Reach |
12.09.2023 11:33 | HVO | hVIVO interim profit jumps on revenue increase; ups full-year guidance | Alliance |
12.09.2023 07:00 | HVO | Interim results | RNS |
05.09.2023 15:47 | SMS, RGL, TPFG | UK earnings, trading statements calendar - next 7 days | Alliance |
01.09.2023 07:00 | HVO | Exercise of Warrants | RNS |
29.08.2023 11:32 | HVO | hVIVO announces plans for new Canary Wharf facility as demand grows | Alliance |
29.08.2023 07:00 | HVO | Plans for a new larger state-of-the-art facility | RNS |
24.08.2023 07:00 | HVO | Notice of Results | RNS |
26.07.2023 14:29 | HVO | IN BRIEF: hVIVO interim revenue grows; in line with expectations | Alliance |
26.07.2023 07:00 | HVO | Trading update | RNS |
25.07.2023 14:25 | HVO | hVIVO secures GBP13.1 million contract for influenza B model | Alliance |
25.07.2023 07:00 | HVO | Flu B challenge model | RNS |
28.06.2023 14:16 | HVO | hVIVO inks deal to manufacture human hMPV virus for challenge trial | Alliance |
28.06.2023 07:00 | HVO | hMPV human challenge model | RNS |
14.06.2023 08:00 | HVO | Director dealings | RNS |
02.06.2023 21:42 | GSK, HVO | IN THE KNOW: hVIVO involvement in drug approval should boost interest | Alliance |
23.05.2023 12:36 | HVO | Result of AGM | RNS |
16.05.2023 15:53 | XSG, WIX, TFIF | UK shareholder meetings calendar - next 7 days | Alliance |
28.04.2023 07:00 | HVO | Annual Report and Notice of AGM | RNS |
26.04.2023 15:44 | TRU, GCAT, UFO | TRADING UPDATES: Skillcast swings to loss, RM Infrastructure NAV down | Alliance |
26.04.2023 07:00 | HVO | FDA Breakthrough and Fast Track for US biotech | Reach |
25.04.2023 14:39 | HVO, AVCT, OTV2 | EARNINGS SUMMARY: hVIVO sees 30% revenue growth; Next 15 lifts payout | Alliance |
25.04.2023 07:00 | HVO | Final results | RNS |
19.04.2023 07:10 | HVO | Notice of Results | RNS |
06.04.2023 15:54 | HVO | Holding(s) in Company | RNS |
03.04.2023 12:13 | HVO | hVIVO touts positive test results from seasonal flu drug, CD388 | Alliance |
03.04.2023 07:00 | HVO | Positive results from flu human challenge study | Reach |
29.03.2023 07:00 | HVO | Presentation at World Vaccine Congress | Reach |
23.03.2023 07:00 | HVO | Exercise of Options | RNS |
16.03.2023 17:32 | PPP, COBR, SLE | TRADING UPDATES: Inspirit Energy reports progress on Inspirit Charger | Alliance |
16.03.2023 17:31 | PPP, COBR, SLE | TRADING UPDATES: Inspirit Energy reports progress on Inspirit Charger | Alliance |
16.03.2023 07:00 | HVO | Omicron human challenge model update | RNS |
06.02.2023 11:00 | HVO | hVIVO signs GBP6.8 million deal to test RSV antiviral drug candidate | Alliance |
06.02.2023 09:05 | HVO | Second Price Monitoring Extn | RNS |
06.02.2023 09:00 | HVO | Price Monitoring Extension | RNS |
06.02.2023 07:05 | HVO | Long Term Incentive Plan / PDMR Notification | RNS |
06.02.2023 07:00 | HVO | £6.8m RSV human challenge contract signed | RNS |
25.01.2023 12:38 | HVO | hVIVO expecting record year; 2023 orderbook soars by 65% against 2022 | Alliance |
25.01.2023 09:06 | HVO | Second Price Monitoring Extn | RNS |
25.01.2023 09:00 | HVO | Price Monitoring Extension | RNS |
25.01.2023 07:00 | HVO | Trading update | RNS |
18.01.2023 15:50 | WJG, VANL, TLW | UK earnings, trading statements calendar - next 7 days | Alliance |
17.01.2023 16:23 | N4P, AVCT, ECOR | TRADING UPDATES: hVIVO wins contract; Dev Clever cancels shares | Alliance |
17.01.2023 07:00 | HVO | EUR3.2m Venn contract with global pharma client | Reach |
04.01.2023 16:40 | HVO | Second Price Monitoring Extn | RNS |
04.01.2023 16:35 | HVO | Price Monitoring Extension | RNS |
04.01.2023 10:40 | HVO | hVIVO signs contract in Asia Pacific to test RSV vaccine candidate | Alliance |
04.01.2023 07:00 | HVO | £5.2m RSV contract and Notice of Trading update | RNS |
03.01.2023 16:40 | HVO | Second Price Monitoring Extn | RNS |
03.01.2023 16:35 | HVO | Price Monitoring Extension | RNS |
03.01.2023 14:05 | HVO | Second Price Monitoring Extn | RNS |
03.01.2023 14:00 | HVO | Price Monitoring Extension | RNS |
03.01.2023 11:05 | HVO | Second Price Monitoring Extn | RNS |
03.01.2023 11:00 | HVO | Price Monitoring Extension | RNS |
19.12.2022 18:20 | VTU, RRR, LTG | TRADING UPDATES: Gulf Keystone chair to retire; JZ Capital cashes in | Alliance |
19.12.2022 07:00 | HVO | Imutex Phase I data published | Reach |
17.11.2022 14:05 | HVO | Second Price Monitoring Extn | RNS |
17.11.2022 14:00 | HVO | Price Monitoring Extension | RNS |